FDA Inspection 1190311 — Mid-South Transplant Foundation
The FDA completed an inspection of Mid-South Transplant Foundation on October 26, 2022 in Cordova, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 26, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Cordova, TN (United States)